Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine

WHO/ISFC task force, 1980, Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies, Br Heart J, 44, 672, 10.1136/hrt.44.6.672 Benson, 1992, Classification of cardiomyopathies of childhood, Prog Pediatr Cardiol, 1, 4, 10.1016/1058-9813(92)90024-G Manolio, 1992, Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop), Am J Cardiol, 69, 1458, 10.1016/0002-9149(92)90901-A Winter, 1995, The role of L-carnitine in pediatric cardiomyopathy, J Child Neurol, 10, 2S45, 10.1177/0883073895010002S07 Ferencz, 1992, Cardiomyopathy in infancy: observations in an epidemiologic study, Pediatr Cardiol, 13, 65, 10.1007/BF00798206 Ablemann, 1984, Classification and natural history of primary myocardial disease, Prog Cardiovasc Dis, 27, 73, 10.1016/0033-0620(84)90020-3 Schwartz, 1996, Clinical approach to genetic cardiomyopathy in children, Circulation, 94, 2021, 10.1161/01.CIR.94.8.2021 Benson, 1992, Dilated cardiomyopathies of childhood, Prog Pediatr Cardiol, 1, 13, 10.1016/1058-9813(92)90030-P Haugland, 1986, Hypertrophic cardiomyopathy in three generations of a large Norwegian family: a clinical, echocardiographic, and genetic study, Br Heart J, 55, 168, 10.1136/hrt.55.2.168 Michels, 1992, The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy, N Engl J Med, 326, 77, 10.1056/NEJM199201093260201 Watkins, 1994, Multiple disease genes cause hypertrophic cardiomyopathy, Br Heart J, 72, S4, 10.1136/hrt.72.6_Suppl.S4 Mestroni, 1994, Familial dilated cardiomyopathy, Br Heart J, 72, S35, 10.1136/hrt.72.6_Suppl.S35 Aroney, 1989, Familial restrictive cardiomyopathy, Aust N Z J Med, 18, 877, 10.1111/j.1445-5994.1988.tb01654.x Fitzpatrick, 1990, Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy, Br Heart J, 63, 114, 10.1136/hrt.63.2.114 Goodwin, 1961, Clinical aspects of cardiomyopathy, BMJ, 1, 69, 10.1136/bmj.1.5219.69 Abelmann, 1984, Classification and natural history of primary myocardial disease, Prog Cardiovasc Dis, 27, 73, 10.1016/0033-0620(84)90020-3 Bezold, 1994, Acquired heart disease in children, Curr Opin Cardiol, 9, 121, 10.1097/00001573-199401000-00015 Davies, 1994, Dilated cardiomyopathy: an introduction to pathology and pathogenesis [abstract], Br Heart J, 72, S24, 10.1136/hrt.72.6_Suppl.S24 Maisch, 1992, Cytolytic anticardiac membrane antibodies in the pathogenesis of myopericarditis, Postgrad Med J, 68, S11 Schwaiger, 1993, Detection of enterovirus ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction, Am Heart J, 126, 406, 10.1016/0002-8703(93)91058-M Weiss, 1992, Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues, J Clin Invest, 90, 156, 10.1172/JCI115830 Keeling, 1992, Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction, Br Heart J, 68, 554, 10.1136/hrt.68.12.554 Liljeqvist, 1993, Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy, J Med Virol, 39, 6, 10.1002/jmv.1890390103 PJ Richardson, HJF Why, LC. Archard, Virus infection and dilated cardiomyopathy, Postgrad Med J 68 (suppl 1) S17-20 (192). Caforio, 1994, Role of autoimmunity in dilated cardiomyopathy, Br Heart J, 72, S30, 10.1136/hrt.72.6_Suppl.S30 Burch, 1964 Keeling, 1994, Link between enteroviruses and dilated cardiomyopathy: serological and molecular data, Br Heart J, 72, S25, 10.1136/hrt.72.6_Suppl.S25 Servidei, 1994, Hereditary metabolic cardiomyopathies, Adv Pediatr, 41, 1 Rees, 1976, Echocardiographic evidence of outflow tract obstruction in Pompe’s disease (glycogen storage disease of the heart), Am J Cardiol, 37, 1103, 10.1016/0002-9149(76)90433-1 Gussenhoven, 1983, Echocardiographic features in the cardiac type of glycogen storage disease II, Eur Heart J, 4, 41, 10.1093/oxfordjournals.eurheartj.a061369 Massoud, 1993, Cardiomyopathy in propionic acidemia, Eur J Pediatr, 152, 441, 10.1007/BF01955907 Cox, 1998, Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency, J Pediatr, 133, 247, 10.1016/S0022-3476(98)70228-8 Bremer, 1984, Fatty acid oxidation and its regulation, 113 Chalmers, 1984, Urinary excretion of L-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of L-carnitine, Pediatr Res, 18, 1325, 10.1203/00006450-198412000-00021 Roe, 1995, Mitochondrial fatty acid oxidation disorders, vol 1, 1501 De Vivo, 1998, L-carnitine supplementation in childhood epilepsy: current perspectives, Epilepsia, 39, 1216, 10.1111/j.1528-1157.1998.tb01315.x Winter, 1987, Plasma carnitine deficiency: clinical observations in 51 pediatric patients, Am J Dis Child, 141, 660, 10.1001/archpedi.1987.04460060076039 Borum, 1995, Carnitine in neonatal nutrition, J Child Neurol, 10, S25 Winter, 1995, The role of L-carnitine in pediatric cardiomyopathy, J Child Neurol, 10, S45 Treem, 1988, Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts, N Engl J Med, 319, 1331, 10.1056/NEJM198811173192006 Waber, 1982, Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport, J Pediatr, 101, 700, 10.1016/S0022-3476(82)80294-1 Tripp, 1984, Plasma carnitine concentrations in cardiomyopathy patients, Biochem Med, 32, 199, 10.1016/0006-2944(84)90073-5 Ino, 1988, Cardiac manifestations in disorders of fat and carnitine metabolism in infancy, J Am Coll Cardiol, 11, 1301, 10.1016/0735-1097(88)90296-3 Spevak, 1990 Regitz, 1990, Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases, Am J Cardiol, 65, 755, 10.1016/0002-9149(90)91383-H Pierpont, 1993 Tein, 1990, Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine- responsive cardiomyopathy, Pediatr Res, 28, 247, 10.1203/00006450-199009000-00020 Bennett, 1996, Endocardial fibroelastosis and primary carnitine deficiency due to a defect in the plasma membrane carnitine transporter, Clin Cardiol, 19, 243, 10.1002/clc.4960190320 Yano, 1997, A new case of malonyl coenzyme A decarboxylase deficiency presenting with cardiomyopathy, Eur J Pediatr, 156, 382, 10.1007/s004310050619 Kothari, 1998, L-carnitine in children with idiopathic dilated cardiomyopathy, Indian Heart J, 50, 59 Winter, 1998, L-carnitine for treatment of a cardiomyopathy, Cardiologia, 43, 685 Summary for the basis of approval for Carnitor for the treatment of carnitine deficiency secondary to inborn errors of metabolism. NDA submitted for FDA approval by sigma-tau Pharmaceuticals, Inc, Gaithersburg, Md, December 16, 1992. Madden, 1995, Acylcarnitine accumulation does not correlate with reperfusion recovery in palmitate-perfused rat hearts, Am J Physiol, 268, H2505